logo

Immunomedics Inc. (IMMU)



Trade IMMU now with
  Date
  Headline
10/23/2020 9:18:09 AM Gilead Completes Transaction To Acquire Immunomedics
10/12/2020 8:09:00 AM Immunomedics Announces FDA Orphan Drug Designation Of Trodelvy For Adult And Pediatric Glioblastoma
9/19/2020 10:34:38 AM Immunomedics Says Trodelvy Extends Survival In Phase 3 ASCENT Study Of Metastatic Triple-Negative Breast Cancer
9/18/2020 8:06:00 AM Immunomedics: Early Intracranial Responses Are Encouraging In Sacituzumab Govitecan In CNS Tumors
8/17/2020 8:14:20 AM Immunomedics Reports FDA Approval Of Samsung Biologics As Antibody Manufacturer For Trodelvy
7/6/2020 7:58:03 AM Immunomedics Says Confirmatory Phase 3 ASCENT Study Of Trodelvy Met Primary Endpoint
4/29/2020 12:03:54 AM Immunomedics Prices Public Offering Of 14.74 Mln Shares At $28.50/Shr